News Wuhan General Group (China), Inc.

Equities

WUHN

US9825691051

Market Closed - OTC Markets Other stock markets 02:46:40 2024-02-02 pm EST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-99.00%

2023	Institute of Biomedical Research Corp. Appoints Adrian J. Maizey to Advisory Board of M2Bio Sciences	CI
2022	Institute of Biomedical Research Corp. agreed to acquire Biomedical and Nutraceutical Assets of Wuhan General Group, Inc. (OTCPK : WUHN).	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

M2Bio Sciences Pharmacology and Clinical Application of CBD	23-09-18	AQ
Institute of Biomedical Research Corp. Appoints Adrian J. Maizey to Advisory Board of M2Bio Sciences	23-07-19	CI
Wuhan General China : Announces Disposal	22-07-18	PU
Institute of Biomedical Research Corp. agreed to acquire Biomedical and Nutraceutical Assets of Wuhan General Group, Inc. (OTCPK : WUHN).	22-07-17	CI
Wuhan General China : Annual disclosure and Financial Statements	22-03-30	PU
Wuhan General Group, Inc. reached an agreement to acquire a 40% stake in Tsime Pharmaceuticals Ltd from Bataung Likate and other shareholders.	21-12-07	CI
Wuhan General (China) : Quarterly Report 30 September 2021	21-11-21	PU
Wuhan General (China) : Quarterly Report 30 September 2021	21-11-19	PU
Wuhan General China : Group, Inc.	21-07-21	AQ
Wuhan General Group, Inc. Announces Appointment of Michael Sachar as CEO of M2bio Sciences Food &Beverage	21-05-20	CI
Wuhan General Group, Inc. announced that it expects to receive $0.45 million in funding from ThreeD Capital Inc.	20-12-29	CI
CORRECTING and REPLACING – Jeff Robinson, CEO of Wuhan, Provides Key Updates and Outlook in a New Audio Interview with SmallCapVoice.com	20-05-22	GL
Jeff Robinson, CEO of Wuhan, Provides Key Updates and Outlook in a New Audio Interview with SmallCapVoice.com	20-05-22	GL
Wuhan to Launch CBD Cosmetics and CBD Infused Coffee in South Africa	19-11-07	GL
Wuhan to Launch CBD Cosmetics and CBD Infused Coffee in South Africa	19-11-07	CI
Wuhan General Group Appoints Distinguished Scientist Dr. Hyder A. Khoja as Chief Scientific Officer	19-08-15	GL
Wuhan General Group Appoints Hyder A. Khoja as Chief Scientific Officer	19-08-15	CI
Wuhan General Group, Inc. Announces Strategic Reorganization to Capitalize Medical Marijuana and Psilocybin Mushroom Industries; Appoints Luka Marjanovic as Head of Product Development for the MJ MedTech Division in South Africa	19-08-07	CI
Wuhan Provides Updates on Corporate, Psilocybin and Cannabis Q3 2019 Milestones	19-07-02	GL
Wuhan Expands Capacity to Produce Medicinal Marijuana and Mushrooms	19-05-17	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Wuhan General Group (China), Inc.

Equities

WUHN

US9825691051

Summary

Filters